Literature DB >> 23381074

Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation.

Subhash Chandra, Dipti Agarwal, Alok Surana.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23381074     DOI: 10.1038/ajg.2012.394

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

Review 1.  Proton Pump Inhibitors and Clostridium Difficile Infection: Are We Propagating an Already Rapidly Growing Healthcare Problem?

Authors:  Rashmee Patil; LeAnn Blankenship
Journal:  Gastroenterology Res       Date:  2013-10-31

2.  Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study.

Authors:  Giorgio Cioni; Pierluigi Viale; Stefania Frasson; Francesco Cipollini; Francesco Menichetti; Nicola Petrosillo; Sergio Brunati; Patrizia Spigaglia; Chiara Vismara; Alessandra Bielli; Fabrizio Barbanti; Giancarlo Landini; Grazia Panigada; Gualberto Gussoni; Erminio Bonizzoni; Giovanni Pietro Gesu
Journal:  BMC Infect Dis       Date:  2016-11-08       Impact factor: 3.090

3.  Impact of clinical pharmacist interventions on inappropriate prophylactic acid suppressant use in hepatobiliary surgical patients undergoing elective operations.

Authors:  Hongli Luo; Qingze Fan; Shunlin Xiao; Kun Chen
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

4.  Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.

Authors:  Hongli Luo; Qingze Fan; Shunlin Xiao; Kun Chen
Journal:  BMC Health Serv Res       Date:  2018-07-11       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.